3. As of noon trading, DaVita HealthCare Partners ( DVA) is down $1.16 (-0.9%) to $129.00 on light volume Thus far, 104,572 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 771,800 shares. The stock has ranged in price between $128.93-$130.45 after having opened the day at $130.09 as compared to the previous trading day's close of $130.16.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.6 billion and is part of the health care sector. The company has a P/E ratio of 30.9, above the S&P 500 P/E ratio of 17.7. Shares are up 17.8% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

As Cyberattacks Rise, This Is Why CEOs Might Want to Prepare for the Worst and Buy Bitcoins

The Price of Bitcoin May Be Rising Because of This One Factor

Crude Surge Marches Dow to Near Record Close

Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound